This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Invincible Biotechnology. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Mikhail Viktorovich Losev: Innovator in Pharmaceutical Compositions
Introduction
Mikhail Viktorovich Losev is a notable inventor based in Novosibirsk, Russia. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on diversion- and abuse-resistant formulations. With a total of 2 patents, his work is recognized for its innovative approach to enhancing the safety and efficacy of active pharmaceutical ingredients.
Latest Patents
Mikhail's latest patents include a composition formulated for diversion- and/or abuse-resistance. This composition features at least one active pharmaceutical ingredient (API) in an acidic form. It also includes a first compound capable of coupling to the acidic form of the API to form a complex that is resistant to separation by conventional methods. Additionally, a second compound is included, which preferentially couples to the first compound, thereby releasing the API from the complex. This innovative approach aims to mitigate the risks associated with the misuse of pharmaceutical products.
Career Highlights
Mikhail is currently associated with Invincible Biotechnology, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is characterized by a commitment to improving drug safety and effectiveness, making him a valuable asset to his organization.
Collaborations
Mikhail collaborates with esteemed colleagues, including Alexandr Vasilievich Troitsky and Michael Libman. Their combined expertise contributes to the advancement of innovative pharmaceutical technologies.
Conclusion
Mikhail Viktorovich Losev stands out as a prominent inventor in the realm of pharmaceutical compositions. His contributions, particularly in developing diversion- and abuse-resistant formulations, highlight his dedication to enhancing drug safety. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile